Response to Comment on “Phenobarbital Versus Benzodiazepine‐Based Pathways for Alcohol Withdrawal Syndrome in Critically Ill Adults: A Systematic Review and Meta‐Analysis”
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-11 · 46 (11)
DOI: 10.1002/phar.70212 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 22.10.2026. Verfasst von Zeeshan M Rizwan. Beteiligte Einrichtung: Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Zeeshan M Rizwan
Zitieren
APA
Rizwan, Z. M. (2026). Response to Comment on “Phenobarbital Versus Benzodiazepine‐Based Pathways for Alcohol Withdrawal Syndrome in Critically Ill Adults: A Systematic Review and Meta‐Analysis”. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(11). https://doi.org/10.1002/phar.70212
Vancouver
Rizwan ZM. Response to Comment on “Phenobarbital Versus Benzodiazepine‐Based Pathways for Alcohol Withdrawal Syndrome in Critically Ill Adults: A Systematic Review and Meta‐Analysis”. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(11). doi:10.1002/phar.70212
BibTeX
@article{Rizwan2026,
author = {Rizwan, Zeeshan M},
title = {Response to Comment on “Phenobarbital Versus Benzodiazepine‐Based Pathways for Alcohol Withdrawal Syndrome in Critically Ill Adults: A Systematic Review and Meta‐Analysis”},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2026},
volume = {46},
number = {11},
doi = {10.1002/phar.70212}
}
EUVIMED